The Use of Therapeutic Peptides to Target and to Kill Cancer Cells

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781

Integrins in cancer: biological implications and therapeutic opportunities

Desgrosellier, J. S., & Cheresh, D. A. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2748 · Cited by 3,855

Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells

Vaux, D. L., Cory, S., & Adams, J. M. (1988) · Nature · doi:10.1038/335440a0 · Cited by 3,219

Requirement of Vascular Integrin α v β 3 for Angiogenesis

Brooks, P. C., Clark, R. A. F., & Cheresh, D. A. (1994) · Science · doi:10.1126/science.7512751 · Cited by 3,020

Cellular uptake of the tat protein from human immunodeficiency virus

Frankel, A. D., & Pabo, C. O. (1988) · Cell · doi:10.1016/0092-8674(88)90263-2 · Cited by 2,782

In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse

Schwarze, S. R., Ho, A. L., Vocero-Akbani, A. M., & Dowdy, S. F. (1999) · Science · doi:10.1126/science.285.5433.1569 · Cited by 2,418

Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor.

Zasloff, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.15.5449 · Cited by 2,305

High Interstitial Fluid Pressure - an Obstacle in Cancer Therapy

Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1456 · Cited by 2,222

Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model

Arap, W., Pasqualini, R., & Ruoslahti, E. (1998) · Science · doi:10.1126/science.279.5349.377 · Cited by 2,054

Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein

Green, M., & Loewenstein, P. M. (1988) · Cell · doi:10.1016/0092-8674(88)90262-0 · Cited by 1,553

X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death

Muchmore, S. W., Sattler, M., Liang, H., Meadows, R. P., Harlan, J. E., Yoon, H. S., Nettesheim, D., Chang, B. S., Thompson, C. B., Wong, S.-L., et al. (1996) · Nature · doi:10.1038/381335a0 · Cited by 1,467

Activation of Apoptosis in Vivo by a Hydrocarbon-Stapled BH3 Helix

Walensky, L. D., Kung, A. L., Escher, I., Malia, T. J., Barbuto, S., Wright, R. D., Wagner, G., Verdine, G. L., & Korsmeyer, S. J. (2004) · Science · doi:10.1126/science.1099191 · Cited by 1,349

Pathophysiologic Implications of Membrane Phospholipid Asymmetry in Blood Cells

Zwaal, R. F. A., & Schroit, A. J. (1997) · Blood · doi:10.1182/blood.v89.4.1121 · Cited by 1,340

Studies on anticancer activities of antimicrobial peptides

Hoskin, D. W., & Ramamoorthy, A. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.11.008 · Cited by 1,296

The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized

van Delft, M. F., Wei, A. H., Mason, K. D., Vandenberg, C. J., Chen, L., Czabotar, P. E., Willis, S. N., Scott, C. L., Day, C. L., Cory, S., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.027 · Cited by 1,240

Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors

Sugahara, K. N., Teesalu, T., Karmali, P. P., Kotamraju, V. R., Agemy, L., Girard, O. M., Hanahan, D., Mattrey, R. F., & Ruoslahti, E. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.10.013 · Cited by 1,136

Structure of Bax

Suzuki, M., Youle, R. J., & Tjandra, N. (2000) · Cell · doi:10.1016/s0092-8674(00)00167-7 · Cited by 1,101

Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs

Sugahara, K. N., Teesalu, T., Karmali, P. P., Kotamraju, V. R., Agemy, L., Greenwald, D. R., & Ruoslahti, E. (2010) · Science · doi:10.1126/science.1183057 · Cited by 1,075

Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia

Konopleva, M., Contractor, R., Tsao, T., Samudio, I., Ruvolo, P. P., Kitada, S., Deng, X., Zhai, D., Shi, Y.-X., Sneed, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.006 · Cited by 1,023

Anti-cancer activity of targeted pro-apoptotic peptides

Ellerby, H. M., Arap, W., Ellerby, L. M., Kain, R., Andrusiak, R., Rio, G. D., Krajewski, S., Lombardo, C. R., Rao, R., Ruoslahti, E., et al. (1999) · Nature Medicine · doi:10.1038/12469 · Cited by 936

Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line

Miyashita, T., & Reed, J. (1993) · Blood · doi:10.1182/blood.v81.1.151.151 · Cited by 882

Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity

Wilson, W. H., O'Connor, O. A., Czuczman, M. S., LaCasce, A. S., Gerecitano, J. F., Leonard, J. P., Tulpule, A., Dunleavy, K., Xiong, H., Chiu, Y.-L., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70261-8 · Cited by 876 · cited 1×

Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.

Pasqualini, R., Koivunen, E., Kain, R., Lahdenranta, J., Sakamoto, M., Stryhn, A., Ashmun, R., Shapiro, L., Arap, W., & Ruoslahti, E. I. (2000) · PubMed · Cited by 859

Substantial Susceptibility of Chronic Lymphocytic Leukemia to BCL2 Inhibition: Results of a Phase I Study of Navitoclax in Patients With Relapsed or Refractory Disease

Roberts, A. W., Seymour, J. F., Brown, J. R., Wierda, W. G., Kipps, T. J., Khaw, S. L., Carney, D. A., He, S. Z., Huang, D. C. S., Xiong, H., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.7898 · Cited by 830

APD: the Antimicrobial Peptide Database

Wang, Z. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh025 · Cited by 808

Transport of Molecules, Particles, and Cells in Solid Tumors

Jain, R. K. (1999) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.1.1.241 · Cited by 691

BCL-2 family antagonists for cancer therapy

Lessene, G., Czabotar, P. E., & Colman, P. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2658 · Cited by 621

De Novo Antimicrobial Peptides with Low Mammalian Cell Toxicity

Javadpour, M. M., Juban, M. M., Lo, W.-C. J., Bishop, S. M., Alberty, J. B., Cowell, S. M., Becker, C. L., & McLaughlin, M. L. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9509410 · Cited by 597

Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes.

Utsugi, T., Schroit, A. J., Connor, J., Bucana, C. D., & Fidler, I. J. (1991) · PubMed · Cited by 594

Isolation and Characterization of Pleurocidin, an Antimicrobial Peptide in the Skin Secretions of Winter Flounder

Cole, A. M., Weis, P., & Diamond, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.18.12008 · Cited by 541

“SMART” Drug Delivery Systems: Double-Targeted pH-Responsive Pharmaceutical Nanocarriers

Sawant, R. M., Hurley, J. P., Salmaso, S., Kale, A., Tolcheva, E., Levchenko, T. S., & Torchilin, V. P. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060080h · Cited by 540

Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes.

Kagan, B. L., Selsted, M. E., Ganz, T., & Lehrer, R. I. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.1.210 · Cited by 532

Host defense peptides as new weapons in cancer treatment

Papo, N., & Shai, Y. (2005) · CMLS Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-4560-2 · Cited by 501

Solution Structure of BID, an Intracellular Amplifier of Apoptotic Signaling

Chou, J. J., Li, H., Salvesen, G. S., Yuan, J., & Wagner, G. (1999) · Cell · doi:10.1016/s0092-8674(00)80572-3 · Cited by 488

Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme

Reardon, D. A., Fink, K. L., Mikkelsen, T., Cloughesy, T. F., O'Neill, A., Plotkin, S., Glantz, M., Ravin, P., Raizer, J. J., Rich, K. M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.7510 · Cited by 481

Solution structure of the antiapoptotic protein bcl-2

Petros, A. M., Medek, A., Nettesheim, D. G., Kim, D. H., Yoon, H. S., Swift, K., Matayoshi, E. D., Oltersdorf, T., & Fesik, S. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041619798 · Cited by 458

Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers

Torchilin, V. P. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.008 · Cited by 449

BAX-dependent transport of cytochrome c reconstituted in pure liposomes

Saito, M., Korsmeyer, S. J., & Schlesinger, P. H. (2000) · Nature Cell Biology · doi:10.1038/35019596 · Cited by 446

Membrane-active host defense peptides – Challenges and perspectives for the development of novel anticancer drugs

Riedl, S., Zweytick, D., & Lohner, K. (2011) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2011.09.004 · Cited by 405

A Stapled BID BH3 Helix Directly Binds and Activates BAX

Walensky, L. D., Pitter, K., Morash, J., Oh, K. J., Barbuto, S., Fisher, J., Smith, E., Verdine, G. L., & Korsmeyer, S. J. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.08.020 · Cited by 383

Antiviral and antitumor peptides from insects

Chernysh, S., Kim, S. I., Bekker, G., Pleskach, V. A., Filatova, N. A., Anikin, V. B., Platonov, V. G., & Bulet, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192301899 · Cited by 375

BH3-only proteins: Orchestrators of apoptosis

Shamas-Din, A., Brahmbhatt, H., Leber, B., & Andrews, D. W. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.11.024 · Cited by 369

Interactions of an antimicrobial peptide, magainin 2, with outer and inner membranes of Gram-negative bacteria

Matsuzaki, K., Sugishita, K.-I., Harada, M., Fujii, N., & Miyajima, K. (1997) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(97)00051-5 · Cited by 363

Antibiotic magainins exert cytolytic activity against transformed cell lines through channel formation.

Cruciani, R. A., Barker, J. L., Zasloff, M., Chen, H. C., & Colamonici, O. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3792 · Cited by 362

Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells

Bafna, S., Kaur, S., & Batra, S. K. (2010) · Oncogene · doi:10.1038/onc.2010.87 · Cited by 360

Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1

Yecies, D., Carlson, N. E., Deng, J., & Letai, A. (2010) · Blood · doi:10.1182/blood-2009-07-233304 · Cited by 360

Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma

Agemy, L., Friedmann-Morvinski, D., Kotamraju, V. R., Roth, L., Sugahara, K. N., Girard, O. M., Mattrey, R. F., Verma, I. M., & Ruoslahti, E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114518108 · Cited by 347

In search of a novel target — Phosphatidylserine exposed by non-apoptotic tumor cells and metastases of malignancies with poor treatment efficacy

Riedl, S., Rinner, B., Asslaber, M., Schaider, H., Walzer, S., Novak, A., Lohner, K., & Zweytick, D. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2011.07.026 · Cited by 331

Mechanism and uses of a membrane peptide that targets tumors and other acidic tissues in vivo

Andreev, O. A., Dupuy, A. D., Segala, M., Sandugu, S., Serra, D. A., Chichester, C. O., Engelman, D. M., & Reshetnyak, Y. K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702439104 · Cited by 321

Ineffectiveness of Doxorubicin Treatment on Solitary Dormant Mammary Carcinoma Cells or Late-developing Metastases

Naumov, G. N., Townson, J. L., MacDonald, I. C., Wilson, S. M., Bramwell, V. H. C., Groom, A. C., & Chambers, A. F. (2003) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000004377.12288.3c · Cited by 305

Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy.

Pastorino, F., Brignole, C., Marimpietri, D., Cilli, M., Gambini, C., Ribatti, D., Longhi, R., Allen, T. M., Corti, A., & Ponzoni, M. (2003) · PubMed · Cited by 296

Doxorubicin-induced apoptosis: Implications in cardiotoxicity

Kalyanaraman, B., Joseph, J., Kalivendi, S., Wang, S., Konorev, E., & Kotamraju, S. (2002) · Oxygen/Nitrogen Radicals: Cell Injury and Disease · doi:10.1007/978-1-4615-1087-1_13 · Cited by 296

Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity

Koren, E., Apte, A., Jani, A., & Torchilin, V. P. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.002 · Cited by 293

Genetic analysis of chemoresistance in primary murine lymphomas

Schmitt, C. A., Rosenthal, C. T., & Lowe, S. W. (2000) · Nature Medicine · doi:10.1038/79542 · Cited by 278

In vitro tumor cell cytolysis mediated by peptide defensins of human and rabbit granulocytes

Lichtenstein, A., Ganz, T., Selsted, M., & Lehrer, R. (1986) · Blood · doi:10.1182/blood.v68.6.1407.1407 · Cited by 263

Spontaneous, pH-Dependent Membrane Insertion of a Transbilayer α-Helix

Hunt, J. F., Rath, P., Rothschild, K. J., & Engelman, D. M. (1997) · Biochemistry · doi:10.1021/bi970147b · Cited by 260

A proapoptotic peptide for the treatment of solid tumors.

Mai, J., Mi, Z., Kim, S.-H., Ng, B., & Robbins, P. D. (2001) · PubMed · Cited by 247

Anticancer efficacy of Magainin2 and analogue peptides.

Baker, M. A., Maloy, W. L., Zasloff, M., & Jacob, L. S. (1993) · PubMed · Cited by 236

Targeting Liposomal Chemotherapy via Both Tumor Cell–Specific and Tumor Vasculature–Specific Ligands Potentiates Therapeutic Efficacy

Pastorino, F., Brignole, C., Paolo, D. D., Nico, B., Pezzolo, A., Marimpietri, D., Pagnan, G., Piccardi, F., Cilli, M., Longhi, R., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2117 · Cited by 233

Antitumor Activity of the Antimicrobial Peptide Magainin II against Bladder Cancer Cell Lines

Lehmann, J., Retz, M. M., Sidhu, S., Suttmann, H., Sell, M., Paulsen, F. P., Harder, J., Unteregger, G., & Stöckle, M. (2006) · European Urology · doi:10.1016/j.eururo.2005.12.043 · Cited by 229

Structure of transmembrane pore induced by Bax-derived peptide: Evidence for lipidic pores

Qian, S., Wang, W., Yang, L., & Huang, H. W. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807764105 · Cited by 227

Targeted delivery of tissue factor to the ED-B domain of fibronectin, a marker of angiogenesis, mediates the infarction of solid tumors in mice.

Nilsson, F., Kosmehl, H., Zardi, L., & Neri, D. (2001) · PubMed · Cited by 212

Treatment of Terminal Peritoneal Carcinomatosis by a Transducible p53-Activating Peptide

Snyder, E. L., Meade, B. R., Saenz, C. C., & Dowdy, S. F. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020036 · Cited by 206

Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases.

Olopade, O. I., Adeyanju, M., Safa, A. R., Hagos, F., Mick, R., Thompson, C. B., & Recant, W. M. (1997) · PubMed · Cited by 203

The neovasculature homing motif NGR: more than meets the eye

Corti, A., Curnis, F., Arap, W., & Pasqualini, R. (2008) · Blood · doi:10.1182/blood-2008-04-150862 · Cited by 198

A Peptide Selected by Biopanning Identifies the Integrin αvβ6 as a Prognostic Biomarker for Nonsmall Cell Lung Cancer

Elayadi, A. N., Samli, K. N., Prudkin, L., Liu, Y.-H., Bian, A., Xie, X., Wistuba, I. I., Roth, J. A., McGuire, M. J., & Brown, K. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0245 · Cited by 189

Energetics of peptide (pHLIP) binding to and folding across a lipid bilayer membrane

Reshetnyak, Y. K., Andreev, O. A., Segala, M., Markin, V. S., & Engelman, D. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804746105 · Cited by 186

Still embedded together binding to membranes regulates Bcl-2 protein interactions

Leber, B. F., Lin, J., & Andrews, D. W. (2010) · Oncogene · doi:10.1038/onc.2010.283 · Cited by 178

Mechanism of Uptake of C105Y, a Novel Cell-penetrating Peptide

Rhee, M., & Davis, P. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509813200 · Cited by 174

Antimicrobial peptides of the Cecropin-family show potent antitumor activity against bladder cancer cells

Suttmann, H., Retz, M. M., Paulsen, F. P., Harder, J., Zwergel, U., Kamradt, J., Wullich, B., Unteregger, G., Stöckle, M., & Lehmann, J. (2008) · BMC Urology · doi:10.1186/1471-2490-8-5 · Cited by 173

The Apoptotic Protein tBid Promotes Leakage by Altering Membrane Curvature

Epand, R. F., Martinou, J., Fornallaz-Mulhauser, M., Hughes, D. W., & Epand, R. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202396200 · Cited by 171

Preliminary experimental anticancer activity of cecropins.

Moore, A., Devine, D., & Bibby, M. C. (1994) · PubMed · Cited by 165

Peptides selected for binding to clotted plasma accumulate in tumor stroma and wounds

Pilch, J., Brown, D. M., Komatsu, M., Järvinen, T. A. H., Yang, M., Peters, D., Hoffman, R. M., & Ruoslahti, E. I. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511219103 · Cited by 162

Pleurocidin-family cationic antimicrobial peptides are cytolytic for breast carcinoma cells and prevent growth of tumor xenografts

Hilchie, A. L., Doucette, C. D., Pinto, D. M., Patrzykat, A., Douglas, S. E., & Hoskin, D. W. (2011) · Breast Cancer Research · doi:10.1186/bcr3043 · Cited by 156

Doxorubicin-induced apoptosis: implications in cardiotoxicity.

Kalyanaraman, B., Joseph, J., Kalivendi, S., Wang, S., Konorev, E. A., & Kotamraju, S. (2002) · PubMed · Cited by 154

Effects of the anti-bacterial peptide cecropin B and its analogs, cecropins B-1 and B-2, on liposomes, bacteria, and cancer cells

Chen, H. M., Wang, W., Smith, D. K., & Chan, S. C. (1997) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(97)00024-x · Cited by 154

Human defensins as cancer biomarkers and antitumour molecules

Droin, N. M., Hendra, J.-B., Ducoroy, P., & Solary, É. (2009) · Journal of Proteomics · doi:10.1016/j.jprot.2009.01.002 · Cited by 154

Is Anticancer Drug Development Heading in the Right Direction?

Hambley, T. W. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3786 · Cited by 153

Manipulating tumor acidification as a cancer treatment strategy.

McCarty, M. F., & Whitaker, J. (2010) · PubMed · Cited by 145

Regulatory Mechanisms in Maintenance and Modulation of Transmembrane Lipid Asymmetry: Pathophysiological Implications

Bevers, E. M., Comfurius, P., & Zwaal, R. F. A. (1996) · Lupus · doi:10.1177/096120339600500531 · Cited by 143

pH-sensitive membrane peptides (pHLIPs) as a novel class of delivery agents

Andreev, O. A., Engelman, D. M., & Reshetnyak, Y. K. (2010) · Molecular Membrane Biology · doi:10.3109/09687688.2010.509285 · Cited by 143

Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery

Gilbert, M. R., Kuhn, J., Lamborn, K. R., Lieberman, F. S., Wen, P. Y., Mehta, M. P., Cloughesy, T. F., Lassman, A. B., DeAngelis, L. M., Chang, S. M., et al. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0650-1 · Cited by 140

In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas

Mason, K. D., Vandenberg, C. J., Scott, C. L., Wei, A. H., Cory, S., Huang, D. C. S., & Roberts, A. W. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809957105 · Cited by 136

Regulation of neovascularization by human neutrophil peptides (α‐defensins): a link between inflammation and angiogenesis

Chavakis, T., Cines, D. B., Rhee, J.-S., Liang, O. D., Schubert, U., Hammes, H., Higazi, A. A., Nawroth, P. P., Preissner, K. T., & Bdeir, K. H. (2004) · The FASEB Journal · doi:10.1096/fj.03-1009fje · Cited by 133

“Smart” Drug Carriers: PEGylated TATp-Modified pH-Sensitive Liposomes

Kale, A. A., & Torchilin, V. P. (2007) · Journal of Liposome Research · doi:10.1080/08982100701525035 · Cited by 131

A mitochondrial targeted fusion peptide exhibits remarkable cytotoxicity

Law, B., Quinti, L., Choi, Y., Weissleder, R., & Tung, C. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0509 · Cited by 127

Self-aggregated pegylated poly (trimethylene carbonate) nanoparticles decorated with c(RGDyK) peptide for targeted paclitaxel delivery to integrin-rich tumors

Jiang, X., Sha, X., Xin, H., Chen, L., Gao, X., Wang, X., Law, K., Gu, J., Chen, Y., Jiang, Y., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.08.055 · Cited by 124

A lipocentric view of peptide-induced pores

Fuertes, G., Giménez, D., Esteban-Martín, S., Sánchez‐Muñoz, O. L., & Salgado, J. (2011) · European Biophysics Journal · doi:10.1007/s00249-011-0693-4 · Cited by 123

Discovery and Identification of α-Defensins as Low Abundant, Tumor-Derived Serum Markers in Colorectal Cancer

Melle, C., Ernst, G., Schimmel, B., Bleul, A., Thieme, H., Kaufmann, R., Mothes, H. K., Settmacher, U., Claussen, U., Kj, H., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.05.014 · Cited by 121

Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdr1 complementary DNA.

Lincke, C. R., van der Bliek, A. M., Schuurhuis, G. J., der Velde-Koerts, T. V., Smit, J. J., & Borst, P. (1990) · PubMed · Cited by 120

Novel Antimicrobial Peptides Derived from Flatfish Genes

Patrzykat, A., Gallant, J. W., Seo, J.-K., Pytyck, J., & Douglas, S. E. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2464-2470.2003 · Cited by 118

Cell membrane fluidity and prognosis of lung cancer

Sok, M., Šentjurc, M., Schara, M., Stare, J., & Rott, T. (2002) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(02)03458-6 · Cited by 107

Peptides corresponding to helices 5 and 6 of Bax can independently form large lipid pores

García‐Sáez, A. J., Coraiola, M., Serra, M. D., Mingarro, I., Müller, P. K., & Salgado, J. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05123.x · Cited by 106

Glypican-3 is overexpressed in lung squamous cell carcinoma, but not in adenocarcinoma

Aviel‐Ronen, S., Lau, S. K., Pintilie, M., Lau, D., Liu, N., Tsao, M., & Jothy, S. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.37 · Cited by 103

Peptides Derived from Apoptotic Bax and Bid Reproduce the Poration Activity of the Parent Full-Length Proteins

García‐Sáez, A. J., Coraiola, M., Serra, M. D., Mingarro, I., Menestrina, G., & Salgado, J. (2005) · Biophysical Journal · doi:10.1529/biophysj.104.058008 · Cited by 102

A Peptide Targeted Contrast Agent Specific to Fibrin-Fibronectin Complexes for Cancer Molecular Imaging with MRI

Ye, F., Jeong, E., Jia, Z., Yang, T., Parker, D., & Lu, Z. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800211r · Cited by 97

Minimal BH3 Peptides Promote Cell Death by Antagonizing Anti-apoptotic Proteins

Moreau, C., Cartron, P., Hunt, A. E., Méflah, K., Green, D. R., Evan, G. I., Vallette, F. M., & Juin, P. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209472200 · Cited by 89

Materials from peptide assembly: towards the treatment of cancer and transmittable disease

Branco, M. C., Sigano, D. M., & Schneider, J. P. (2011) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2011.03.021 · Cited by 79

The combined effects of antibacterial peptide cecropin A and anti-cancer agents on leukemia cells.

Hui, L., Leung, K., & Chen, H. M. (2002) · PubMed · Cited by 77

RGD peptide-mediated chitosan-based polymeric micelles targeting delivery for integrin-overexpressing tumor cells

Du, Y., Cai, Liu, P., Li, X., Huang, X., Ye, Y.-Q., Chen, F., Yuan, & Hu, F.-Q. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s26670 · Cited by 77

Peptide Targeting of Platinum Anti-Cancer Drugs

Ndinguri, M. W., Solipuram, R., Gambrell, R. P., Aggarwal, S., & Hammer, R. P. (2009) · Bioconjugate Chemistry · doi:10.1021/bc900065r · Cited by 76

Enhancement of cytotoxicity of antimicrobial peptide magainin II in tumor cells by bombesin-targeted delivery

Liu, S., Yang, H., Wan, L., Cai, H., Li, S., Li, Y., Cheng, J., & Lu, X. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.162 · Cited by 76

The cytotoxic effects of human neutrophil peptide-1 (HNP1) and lactoferrin on oral squamous cell carcinoma (OSCC) in vitro

McKeown, S., Lundy, F. T., Nelson, J., Lockhart, D., Irwin, C. R., Cowan, C. G., & Marley, J. J. (2006) · Oral Oncology · doi:10.1016/j.oraloncology.2005.11.005 · Cited by 76

Effect of defensin peptides on eukaryotic cells: primary epithelial cells, fibroblasts and squamous cell carcinoma cell lines

Nishimura, M., Abiko, Y., Kurashige, Y., Takeshima, M., Yamazaki, M., Kusano, K., Saitoh, M., Nakashima, K., Inoue, T., & Kaku, T. (2004) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2004.07.001 · Cited by 75

Experimental local therapy of human melanoma with lytic magainin peptides

Sloballe, P. W., Maloy, W. L., Myrga, M. L., Jacob, L. S., & Herlyn, M. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600225 · Cited by 74

Interaction of pleurocidin and its analogs with phospholipid membrane and their antibacterial activity

Yoshida, K., Mukai, Y., Niidome, T., Higuchi, C. T., Tokunaga, Y., Hatakeyama, T., & Aoyagi, H. (2001) · Journal of Peptide Research · doi:10.1034/j.1399-3011.2001.00802.x · Cited by 72

Plasma membrane lipid composition of vinblastine sensitive and resistant human leukaemic lymphoblasts

May, G. L., Wright, L. C., Dyne, M., Mackinnon, W. B., Fox, R. M., & Mountford, C. E. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910420517 · Cited by 72

The cell penetrating ability of the proapoptotic peptide, KLAKLAKKLAKLAK fused to the N-terminal protein transduction domain of translationally controlled tumor protein, MIIYRDLISH

Kim, H. Y., Kim, S., Youn, H., Chung, J.-K., Shin, D. H., & Lee, K. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.074 · Cited by 69

Human neutrophil peptide defensins induce single strand DNA breaks in target cells

Gera, J., & Lichtenstein, A. K. (1991) · Cellular Immunology · doi:10.1016/0008-8749(91)90136-y · Cited by 68

Cell‐penetrating chitosan/doxorubicin/TAT conjugates for efficient cancer therapy

Lee, J., Choi, Y., Suh, J. S., Kwon, Y. M., Yang, V. C.-M., Lee, S. J., Chung, C., & Park, Y. (2010) · International Journal of Cancer · doi:10.1002/ijc.25578 · Cited by 66

Amphipathic Peptide-Based Fusion Peptides and Immunoconjugates for the Targeted Ablation of Prostate Cancer Cells

Rege, K., Patel, S. J., Megeed, Z., & Yarmush, M. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3658 · Cited by 65

Design of a dual-ligand system using a specific ligand and cell penetrating peptide, resulting in a synergistic effect on selectivity and cellular uptake

Takara, K., Hatakeyama, H., Ohga, N., Hida, K., & Harashima, H. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.05.002 · Cited by 64

The anticancer activity of lytic peptides is inhibited by heparan sulfate on the surface of the tumor cells

Fadnes, B., Rekdal, Ø., & Uhlin‐Hansen, L. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-183 · Cited by 61

Membrane Fluidity and Cancer Metastasis

Sherbet, G. V. (2008) · Experimental Cell Biology · doi:10.1159/000163526 · Cited by 59

Targeting acidic diseased tissue: New technology based on use of the pH (Low) Insertion Peptide (pHLIP).

Andreev, O. A., Engelman, D. M., & Reshetnyak, Y. K. (2009) · PubMed · Cited by 57

Bax-derived membrane-active peptides act as potent and direct inducers of apoptosis in cancer cells

Valero, J. G., Sancey, L., Kucharczak, J., Guillemin, Y., Giménez, D., Prudent, J., Gillet, G., Salgado, J., Coll, J., & Aouacheria, A. (2011) · Journal of Cell Science · doi:10.1242/jcs.076745 · Cited by 56

High prevalence of bcl-2 oncoprotein expression in small cell lung cancer

Surgery, T. (1995) · Lung Cancer · doi:10.1016/0169-5002(95)90567-7 · Cited by 54

Relative Spatial Positions of Tryptophan and Cationic Residues in Helical Membrane-active Peptides Determine Their Cytotoxicity

Rekdal, Ø., Haug, B. E., Kalaaji, M., Hunter, H. N., Lindin, I., Israelsson, I., Solstad, T., Yang, N., Brandl, M., Mantzilas, D., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.279281 · Cited by 52

A novel pH-responsive polysaccharidic ionic complex for proapoptotic d-(KLAKLAK)2 peptide delivery

Lee, B. R., Oh, K. T., Oh, Y. T., Baik, H. J., Park, S. Y., Youn, Y. S., & Lee, E. S. (2011) · Chemical Communications · doi:10.1039/c0cc03590d · Cited by 44

Overcoming blocks in apoptosis with BH3-mimetic therapy in haematological malignancies

Khaw, S. L., Huang, D. C. S., & Roberts, A. W. (2011) · Pathology · doi:10.1097/pat.0b013e32834b1b34 · Cited by 42

Role of Membrane Lipids for the Activity of Pore Forming Peptides and Proteins

Fuertes, G., Giménez, D., Esteban-Martín, S., Sáez, A. J. G., Sánchez, O. A., & Salgado, J. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6327-7_4 · Cited by 36

Intracellular Delivery of Nanoparticles with CPPs

Sawant, R. R., & Torchilin, V. P. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-919-2_31 · Cited by 33

Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma

Santoro, A., Pressiani, T., Citterio, G., Rossoni, G., Donadoni, G., Pozzi, F., Rimassa, L., Personeni, N., Bozzarelli, S., Rossoni, G., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605858 · Cited by 32

Bcl-2 Expression in Non-Small Cell Lung Cancers: Higher Frequency of Expression in Squamous Cell Carcinomas with Earlier pT Status

Dosaka‐Akita, H., Katabami, M., Hommura, H., Fujioka, Y., Katoh, H., & Kawakami, Y. (1999) · Oncology · doi:10.1159/000011974 · Cited by 28

Crumpled structure of the custom hydrophobic lytic peptide cecropin B3

Srisailam, S., Kumar, T. K. S., Arunkumar, A. I., Leung, K. W., Yu, C., & Chen, H. M. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02345.x · Cited by 27

Cell delivery of Met docking site peptides inhibit angiogenesis and vascular tumor growth

Cantelmo, A. R., Cammarota, R., Noonan, D. M., Focaccetti, C., Comoglio, P. M., Prat, M., & Albini, A. (2010) · Oncogene · doi:10.1038/onc.2010.267 · Cited by 25

Multiple Triphenylphosphonium Cations as a Platform for the Delivery of a Pro-Apoptotic Peptide

Kolevzon, N., Kuflik, U., Shmuel, M., Benhamron, S., Ringel, I., & Yavin, E. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0494-6 · Cited by 20

Effects of the Synthetic Coprisin Analog Peptide, CopA3 in Pathogenic Microorganisms and Mammalian Cancer Cells

Kim, I.-W. (2012) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1109.09014 · Cited by 15

Expression and Functional Characterization of Tumor-Targeted Fusion Protein Composed of NGR Peptide and 15-kDa Actin Fragment

Lei, H., Cao, P., Miao, G., Lin, Z., & Diao, Z. (2010) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-009-8901-8 · Cited by 12

Biomedical applications of nisin

Shin, J. M., Gwak, J. W., Kamarajan, P., Fenno, J. C., Rickard, A. H., & Kapila, Y. L. (2016) · Journal of Applied Microbiology · doi:10.1111/jam.13033 · Cited by 607

Peptides as drug delivery vehicles across biological barriers

Ghosh, D., Peng, X., Leal, J., & Mohanty, R. P. (2018) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-017-0374-0 · Cited by 102

The Role of RhoH in TCR Signalling and Its Involvement in Diseases

Ahmad Mokhtar, A. M., Hashim, I. F., Mohd Zaini Makhtar, M., Salikin, N. H., & Amin-Nordin, S. (2021) · Cells · doi:10.3390/cells10040950 · Cited by 25

Enhancing microalgal proteins for nutraceutical and functional food applications

Kaur, M., Bhatia, S., Bagchi, D., Tak, Y., Kaur, G., Kaur, C., Kaur, A., & Sharma, N. (2025) · Future Foods · doi:10.1016/j.fufo.2025.100564 · Cited by 19